STORY FROM: Drugs & Medical Devices
New Federal Lawsuit Says Contaminated Valsartan Caused La. Man’s Death
November 16, 2018
LAFAYETTE, La. — The widow of a man who died from kidney cancer after ingesting allegedly contaminated valsartan has filed a wrongful death action against the drug’s makers in Louisiana federal court, accusing them of knowing the drug was adulterated, yet touting its safety to doctors and consumers.
In the Nov. 15 complaint filed in the U.S. District Court for the Western District of Louisiana, the plaintiff further alleges defendants Zhejiang Huahai Pharmaceutical Co., Huahai US Inc., Solco Healthcare U.S. and Prinston Pharmaceutical Inc. ignored warning signs of contamination at the Chinese manufacturing plant where the drug is made.
Associated Law Firms
Law Offices of Kenneth W. DeJean